查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599243

動物抗菌藥物敏感性測試市場：按產品類型、動物類型、最終用戶分類 - 全球預測 2025-2030

Veterinary Antimicrobial Susceptibility Testing Market by Product (Accessories & Consumables, Automated Ast Instruments, Culture Media), Animal Type (Companion Animals, Food-Producing Animals), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年獸藥敏感性測試市值為1.0459億美元，預計2024年將達到1.1338億美元，複合年成長率為8.50%，到2030年將達到1.8519億美元，預計將達到1000萬美元。

獸醫抗菌藥物敏感性測試 (VAST) 對於診斷和管理動物感染疾病、促進抗菌藥物的正確使用以及減輕抗菌藥物抗藥性 (AMR) 的傳播至關重要。對 VAST 的需求源於對確保動物健康和福利、保護公眾健康以及控制抗菌藥物有效性的迫切需要，以及對 AMR 的日益擔憂。 VAST 適用於臨床環境、農業環境和研究機構，主要用於牲畜、伴同性動物和水產養殖。對市場成長的洞察是由不斷提高的動物健康意識、診斷技術的創新以及提倡負責任地使用抗生素的監管政策所推動的。分子診斷技術的出現提高了藥敏檢測的速度和準確性，大大促進了市場的擴張。此外，獸醫服務的日益私有化和全球寵物擁有率的上升正在推動需求。然而，顯著的限制，特別是對於小規模營運商來說，包括測試設備和測試過程的高成本，以及測試程序缺乏全球標準化。進一步的挑戰包括抗菌素抗藥性模式的複雜性以及最新區域敏感性資料的有限性。儘管存在這些挑戰，但在開發快速、具有成本效益的就地檢驗和整合資料管理系統以提高診斷效率和抗菌藥物管理方面仍然存在有希望的機會。為了抓住這一觀點，相關人員應該投資於自動化和小型化測試平台的研究和開發，並在全球範圍內合作協調敏感性測試方法。創新領域包括診斷中奈米技術的進步以及人工智慧在抗菌藥物使用模式預測分析中的應用。 VAST市場是一個充滿活力的市場，其特點是技術進步和監管影響。對不斷發展的行業標準和技術進步做出策略性反應的相關人員可以確保競爭力並為全球抗菌藥物管理工作做出有意義的貢獻。

主要市場統計
基準年[2023] 10459萬美元
預測年份 [2024] 11338萬美元
預測年份 [2030] 1.8519 億美元
複合年成長率（%） 8.50%

市場動態：快速發展的獸用抗生素敏感性測試市場的關鍵市場洞察

供需的動態交互作用正在改變獸用抗菌藥敏感性測試市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 飼養的伴同性動物和牲畜數量增加
    • 牲畜死亡率和疾病率增加
    • 政府努力製定解決抗菌素抗藥性的國家戰略
  • 市場限制因素
    • 效率低下，設備和材料成本上升
  • 市場機會
    • 獸藥藥敏試驗技術進展
    • 增加供應商的策略聯盟和投資
  • 市場挑戰
    • 藥物動力學特徵存在較大個體差異

波特五力：開拓動物抗菌藥物敏感性測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解動物抗菌藥物敏感性測試市場的外部影響

外部宏觀環境因素在塑造動物抗菌藥物敏感性測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解動物藥敏檢測市場的競爭狀況

獸用抗生素敏感性測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣獸用抗菌藥敏感性測試市場供應商的績效評估

FPNV定位矩陣是評估獸用抗菌藥敏感性測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為動物抗菌藥物敏感性測試市場的成功指明道路

對於旨在加強其在全球市場的影響力的公司來說，對動物抗菌藥物敏感性測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 飼養寵物和牲畜的數量增加
      • 牲畜死亡率和疾病率增加
      • 政府努力製定解決抗菌素抗藥性的國家戰略
    • 抑制因素
      • 效率低下，設備材料成本高
    • 機會
      • 獸藥藥敏試驗技術進展
      • 增加供應商的策略聯盟和投資
    • 任務
      • 藥物動力學特徵存在較大個體差異
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物抗菌藥物敏感性測試市場：依產品

  • 配件和用品
  • 自動AST設備
  • 文化媒體
  • 磁碟和板

第7章依動物類型分類的動物藥敏測試市場

  • 伴同性動物
  • 食用動物

第8章動物抗菌藥物敏感性測試市場：依最終用戶分類

  • 獸醫醫學參考研究所
  • 獸醫研究所和大學

第9章：美洲動物抗菌藥物敏感性測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太動物藥敏測試市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章：歐洲、中東和非洲動物藥敏檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bioguard Corporation
  • BioMerieux SA
  • Bruker Corporation
  • FASTinov SA
  • Hardy Diagnostics
  • Himedia Laboratories
  • IDEXX Laboratories, Inc.
  • LABORATORIOS CONDA, SA
  • Liofilchem Srl
  • Mast Group Ltd.
  • Neogen Corporation
  • SSI Diagnostica A/S
  • Synoptics Ltd
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FD3F12D533B4

The Veterinary Antimicrobial Susceptibility Testing Market was valued at USD 104.59 million in 2023, expected to reach USD 113.38 million in 2024, and is projected to grow at a CAGR of 8.50%, to USD 185.19 million by 2030.

Veterinary Antimicrobial Susceptibility Testing (VAST) is integral to diagnosing and managing infectious diseases in animals, facilitating the correct use of antimicrobials, and mitigating the spread of antimicrobial resistance (AMR). The necessity of VAST arises from the pressing need to ensure animal health and welfare, safeguard public health, and manage antimicrobial efficacy amid escalating AMR concerns. It finds applications in clinical settings, agricultural practices, and research institutions, primarily focusing on livestock, companion animals, and aquaculture. Insights into market growth are driven by increasing animal health awareness, innovation in diagnostic technologies, and regulatory policies advocating for responsible antimicrobial use. The advent of molecular diagnostic technologies, enhancing the speed and precision of susceptibility testing, is a significant contributor to market expansion. Moreover, the growing privatization of veterinary services and the rise in pet ownership worldwide are bolstering demand. However, notable limitations include high costs of testing equipment and processes, especially for small-scale operators, and a lack of standardization in testing procedures globally. Additional challenges stem from the complexity of AMR patterns and the limited availability of updated regional susceptibility data. Despite these challenges, there are promising opportunities in developing rapid, cost-effective point-of-care testing solutions and integrated data management systems that enhance diagnostic efficiency and antimicrobial stewardship. To seize these prospects, stakeholders should invest in R&D for automated and miniaturized testing platforms and collaborate on global initiatives for harmonizing susceptibility testing methodologies. Innovation areas include advancing nanotechnology in diagnostics and leveraging artificial intelligence for predictive analytics in antimicrobial usage patterns. The VAST market is dynamic, characterized by technological advancements and regulatory influences. Stakeholders who strategically align their operations with evolving industry standards and technological progress can secure a competitive edge and contribute meaningfully to global antimicrobial management efforts.

KEY MARKET STATISTICS
Base Year [2023] USD 104.59 million
Estimated Year [2024] USD 113.38 million
Forecast Year [2030] USD 185.19 million
CAGR (%) 8.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Antimicrobial Susceptibility Testing Market

The Veterinary Antimicrobial Susceptibility Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Rising mortality and disease rates in farm animals
    • Government initiatives to develop national strategy to address antimicrobial resistance
  • Market Restraints
    • Lack of efficiency and higher cost in terms of equipment and materials
  • Market Opportunities
    • Technological advances in veterinary antimicrobial susceptibility testing
    • Increasing strategic alliances and investments by vendors
  • Market Challenges
    • Large inter-individual differences in pharmacokinetic profiles

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Antimicrobial Susceptibility Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Antimicrobial Susceptibility Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Antimicrobial Susceptibility Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Antimicrobial Susceptibility Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Antimicrobial Susceptibility Testing Market

A detailed market share analysis in the Veterinary Antimicrobial Susceptibility Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Antimicrobial Susceptibility Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Antimicrobial Susceptibility Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Antimicrobial Susceptibility Testing Market

A strategic analysis of the Veterinary Antimicrobial Susceptibility Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bioguard Corporation, BioMerieux S.A., Bruker Corporation, FASTinov S.A., Hardy Diagnostics, Himedia Laboratories, IDEXX Laboratories, Inc., LABORATORIOS CONDA, S.A., Liofilchem S.r.l., Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synoptics Ltd, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories & Consumables, Automated Ast Instruments, Culture Media, and Disks & Plates.
  • Based on Animal Type, market is studied across Companion Animals and Food-Producing Animals.
  • Based on End-user, market is studied across Veterinary Reference Laboratories and Veterinary Research Institutes & Universities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Rising mortality and disease rates in farm animals
      • 5.1.1.3. Government initiatives to develop national strategy to address antimicrobial resistance
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of efficiency and higher cost in terms of equipment and materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advances in veterinary antimicrobial susceptibility testing
      • 5.1.3.2. Increasing strategic alliances and investments by vendors
    • 5.1.4. Challenges
      • 5.1.4.1. Large inter-individual differences in pharmacokinetic profiles
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Antimicrobial Susceptibility Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories & Consumables
  • 6.3. Automated Ast Instruments
  • 6.4. Culture Media
  • 6.5. Disks & Plates

7. Veterinary Antimicrobial Susceptibility Testing Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Companion Animals
  • 7.3. Food-Producing Animals

8. Veterinary Antimicrobial Susceptibility Testing Market, by End-user

  • 8.1. Introduction
  • 8.2. Veterinary Reference Laboratories
  • 8.3. Veterinary Research Institutes & Universities

9. Americas Veterinary Antimicrobial Susceptibility Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Bioguard Corporation
  • 4. BioMerieux S.A.
  • 5. Bruker Corporation
  • 6. FASTinov S.A.
  • 7. Hardy Diagnostics
  • 8. Himedia Laboratories
  • 9. IDEXX Laboratories, Inc.
  • 10. LABORATORIOS CONDA, S.A.
  • 11. Liofilchem S.r.l.
  • 12. Mast Group Ltd.
  • 13. Neogen Corporation
  • 14. SSI Diagnostica A/S
  • 15. Synoptics Ltd
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED AST INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISKS & PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY VETERINARY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2023